LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Buy this little-known chip design stock benefiting from AI growth, Bank of America says

Chaim Potok by Chaim Potok
August 22, 2024
in Investing
Buy this little-known chip design stock benefiting from AI growth, Bank of America says
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

[ad_1]

Investors may want to keep an eye on a chip design stock that is poised to benefit from ongoing artificial intelligence tailwinds, according to Bank of America. Analyst Vivek Arya reiterated his buy rating and lifted estimates on Synopsys in a report on Thursday, citing ongoing electronic design automation momentum and a steady AI product ramp. SNPS YTD mountain Shares over the last year “Overall, we believe SNPS remains a key beneficiary of rising semi complexity led by AI and increased chip design activity by an expanding set of customers,” he wrote. Shares of the semiconductor stock have added 28% over the past year, outperforming the S & P 500 by half a percentage point, as Wall Street stepped up bets on potential AI winners. Arya expects Synopsys’ core business to see low double-digit growth through 2025 as companies allocate more research and development dollars to semiconductor spending. Shares should also gain from a “healthy” $7.9 billion backlog as chip design starts to accelerate and AI products roll out. “AI products (VSO.ai) introduce another monetization lever which is delivering a +20% uplift to contracts where adoption remains in early days,” he added. Arya reiterated his $650 price objective, implying 15% upside from Wednesday’s close, and raised revenue estimates for 2025 and 2026 by 5% and 6%, respectively. Operating profit margins should also expand to 40% by the second half of 2025. Arya added that closure of the company’s $35 billion deal to buy graphics software maker Ansys could unlock a $31 billion total addressable market and $400 million in “potential revenue synergies.”

[ad_2]

Source link

You might also like

Tuesday’s big stock stories: What’s likely to move the market in the next trading session

Investor Joe Terranova says one public stock is a back door way to play the booming fortunes of private Anthropic

This Chinese video platform will outperform as it ramps up game releases, says Morgan Stanley

Share30Tweet19
Previous Post

Catella APAM facilitates sale of Trowbridge leisure park for £11.37m | Property Week

Next Post

AI drone ‘hellscape’ plan for Taiwan, LLMs too dumb to destroy humanity: AI Eye

Chaim Potok

Chaim Potok

Recommended For You

Tuesday’s big stock stories: What’s likely to move the market in the next trading session
Investing

Tuesday’s big stock stories: What’s likely to move the market in the next trading session

April 14, 2026
Investor Joe Terranova says one public stock is a back door way to play the booming fortunes of private Anthropic
Investing

Investor Joe Terranova says one public stock is a back door way to play the booming fortunes of private Anthropic

April 13, 2026
This Chinese video platform will outperform as it ramps up game releases, says Morgan Stanley
Investing

This Chinese video platform will outperform as it ramps up game releases, says Morgan Stanley

April 13, 2026
Nike gets another downgrade. HSBC says turnaround strategy is now a ‘show me’ story
Investing

Nike gets another downgrade. HSBC says turnaround strategy is now a ‘show me’ story

April 13, 2026
Next Post
AI drone ‘hellscape’ plan for Taiwan, LLMs too dumb to destroy humanity: AI Eye

AI drone ‘hellscape’ plan for Taiwan, LLMs too dumb to destroy humanity: AI Eye

Related News

The rich often misjudge the potency of their retirement savings, says report

The rich often misjudge the potency of their retirement savings, says report

June 12, 2023
Gilead Sciences says FDA has approved Veklury in COVID patients with severe kidney disease

Gilead Sciences says FDA has approved Veklury in COVID patients with severe kidney disease

July 14, 2023
Historically Accurate Macro Signal Hints at a Bitcoin Price Bottom

Historically Accurate Macro Signal Hints at a Bitcoin Price Bottom

March 13, 2026

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?